Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation

Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation

Meningiomas are primary central nervous system (CNS) tumors that originate from the arachnoid cells of the meninges. Recurrence occurs in higher grade meningiomas and a small subset of Grade I meningiomas with benign histology. Currently, there are no established circulating tumor markers which can...

Full description

Bibliographic Details
Main Authors: Erdogan Pekcan Erkan, Thomas Ströbel, Christian Dorfer, Markus Sonntagbauer, Andreas Weinhäusel, Nurten Saydam, Okay Saydam
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
meningioma
proximity extension assay
biomarker
serum biomarker
CNS tumors
high-throughput immunoassay cancer panel
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01031/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01031/full

Similar Items